Australia is experience innovative therapy for weight issues: Retatrutide. The dual molecule – working on both GLP-1 and GIP receptors – has remarkable results in clinical trials, indicating meaningful drops in body fat. While regulatory clearance is pending with the Therapeutic Goods Administration (TGA), many people battling being overweight